Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR

Leukemia

Volumn 14, Issue 8, 2000, Pages 1419-1425

  Bruggemann M ^a   Droese, J ^a   Bolz, I ^a   Luth P ^a   Pott, C ^a   Von Neuhoff, N ^a   Scheuering, U ^b   Kneba, M ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Acute lymphoblastic leukemia; IgH CDR3; Minimal residual disease; Real time quantitative PCR

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ALLELE; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOGENETICS; LYMPHATIC LEUKEMIA; MEDICAL ASSESSMENT; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0033902614     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401831     Document Type: Article

References (31)

1. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukemia by molecular analysis
2. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of δ and γ T-cell receptor genes
3. Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia
4. Measurement of residual disease during remission in childhood acute lymphoblastic leukemia
5. Clinical significance of minimal residual disease in childhood acute lymphoblastic Leukemia
6. Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood
7. Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome
8. Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas: A critical reappraisal of molecular strategies
9. Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complemetarity determining region III standards
10. Quantitative PCR of the immunoglobulin heavy chain gene using genomic DNA
11. Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes
12. Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma
13. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes
14. Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessment of minimal residual disease (MRD)
15. Detection of specific polymerase chain reaction product by utilizing the 5'- 3' exonuclease activity of Thermus aquaticus DNA polymerase
16. A novel method for real time quantitative RT-PCR
17. Real time quantitative PCR
18. Use of UITma DNA polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions
19. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes
20. Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias
21. The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non-allelic genes
22. Extensive allelic sequence variation in the J region of the human immunoglobulin heavy chain gene locus
23. Organization of human immunoglobulin heavy chain diversity gene loci
24. Immunoglobulin heavy chain gene expression in peripheral blood lymphocytes
25. Mixed population of V(H) gene segments and CDR3 distribution in the expressed Cα and Cγ repertoires
26. Sequence of the human immunoglobulin diversity (D) segment locus: A systematic analysis provides no evidence for the use of DIR segments,. Inverted D segments, 'minor' D segments or D-D recombination
27. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction
28. Follow-up of residual disease (MRD) in B lineage akute leukemia using a simplified PCR strategy: Evolution of MRD rather than its detection is correlated with clinical outcome
29. Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukemia reveals differences in treatment response
30. Quantitation of targets for PCR by use of limiting dilution
31. Quantitation of leukemia clone-specific antigen gene rearrangements by a single-step PCR and fluorescence-based detection method